Nanobiotix (NANO) | Stock Overview & Key Data
Nanobiotix Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: €33.12 on February 10, 2014
Explore how other French stocks compare to their 52-week ranges: View FR Market 52-Week Insights
Key Statistics
Financial Highlights
Profitability
Returns and Earnings
Growth
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Nanobiotix NANO | 178.24M Mid-cap | 0.97% | 1.46% | 41.02% | 39.13% | 35.50% | -12.30% | 26.63% | -38.51% |
| Riber S.A ALRIB | 65.00M Small-cap | -3.41% | 18.88% | 43.46% | 5.26% | 18.06% | 32.95% | 104.17% | 143.26% |
| Tronic's ALTRO | 60.16M Small-cap | 17.19% | 54.32% | 65.93% | 37.61% | 36.36% | 70.24% | 38.83% | -4.67% |
| Société Générale GLE | 37.36B Large-cap | 2.90% | 1.92% | 47.20% | 84.70% | 84.49% | 105.24% | 133.22% | 221.08% |
| Nokia Oyj NOKIA | 24.34B Large-cap | 0.46% | -7.35% | 4.26% | -1.34% | 1.85% | 21.61% | -4.57% | 20.60% |
| Capgemini SE CAP | 24.72B Large-cap | -5.45% | -8.93% | 13.91% | -14.50% | -12.45% | -24.01% | -13.28% | 39.33% |
Ownership & Short Interest
Nanobiotix Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Nanobiotix would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
In the last 52 weeks, Nanobiotix reached a high of €5.30 (on August 28, 2024) and a low of €2.62 (on April 7, 2025).
Curious about Nanobiotix's size and valuation? Its market capitalization stands at 178.24M. When it comes to valuation, the P/E ratio (trailing twelve months) is -2.68, and the forward P/E (looking ahead) is -3.55.
As for dividends, Nanobiotix isn't currently offering a significant yield, or that specific data isn't available right now.
When looking at Nanobiotix, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Riber S.A
ALRIB65.00M Technology Semiconductor Equipment & Materials 32.95% 104.17% Tronic's
ALTRO60.16M Technology Semiconductor Equipment & Materials 70.24% 38.83% Société Générale
GLE37.36B Financial Services Banks - Regional 105.24% 133.22% Nokia Oyj
NOKIA24.34B Technology Communication Equipment 21.61% -4.57% Capgemini SE
CAP24.72B Technology Information Technology Services -24.01% -13.28% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
To get a sense of Nanobiotix's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 103.70%, the Debt to Equity ratio from the most recent quarter is -0.77, and its Gross Profit Margin stands at N/A.
Looking at Nanobiotix's growth, its revenue over the trailing twelve months (TTM) was €-7M. Compared to the same quarter last year (YoY), quarterly revenue grew by N/A, and quarterly earnings saw a YoY growth of N/A.
Wondering who owns Nanobiotix stock? Company insiders (like executives and directors) hold about 15.59% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 28.49%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.